Enanta Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Enanta Pharmaceuticals Inc
TickerENTA
CIK #0001177648
CUSIP29251M106
SectorLife Sciences - Pharmaceutical Preparations
Address500 Arsenal Street, Watertown, MA 02472
Source [EDGAR]
CIK Filing 2011 - 2025
[0001177648] 10-K
[0001177648] 10-Q
[0001177648] 3
[0001177648] 4
[0001177648] 8-K
[0001177648] SC 13D
[0001177648] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Integrated Core Strategies US LLC Enanta Pharmaceuticals Inc [2025-01-22] 0.0
Krensavage Asset Management LLC Enanta Pharmaceuticals Inc [2024-02-27] 0.0
Millennium Management LLC Enanta Pharmaceuticals Inc [2024-01-11] 6.2
Millennium Management LLC Enanta Pharmaceuticals Inc [2023-11-16] 4.9
Armistice Capital LLC Enanta Pharmaceuticals Inc [2023-02-14] 0.99
BlackRock Inc Enanta Pharmaceuticals Inc [2023-01-31] 18.0
First Manhattan Co Enanta Pharmaceuticals Inc [2022-02-15] 5.46
Armistice Capital LLC Enanta Pharmaceuticals Inc [2021-02-16] 6.7
Renaissance Technologies LLC Enanta Pharmaceuticals Inc [2021-02-10] 5.13
State Street Corp Enanta Pharmaceuticals Inc [2021-02-09] 5.84
BlackRock Inc Enanta Pharmaceuticals Inc [2021-01-25] 17.0
Farallon Capital Management LLC Enanta Pharmaceuticals Inc [2019-09-27] 1.1
Price T Rowe Associates Inc /MD/ Enanta Pharmaceuticals Inc [2019-02-14] 5.5
Vanguard Group Inc Enanta Pharmaceuticals Inc [2019-02-11] 7.85
LULY Jay R Enanta Pharmaceuticals Inc [2019-01-18] 5.0
Farallon Capital Management LLC Enanta Pharmaceuticals Inc [2018-05-10] 1.1
First Manhattan Co Enanta Pharmaceuticals Inc [2018-02-09] 6.31
First Manhattan Co Enanta Pharmaceuticals Inc [2018-02-09] 6.31
Krensavage Asset Management LLC Enanta Pharmaceuticals Inc [2017-02-15] 4.6
Apex Capital Management Enanta Pharmaceuticals Inc [2016-02-10] 5.0
BlackRock Inc Enanta Pharmaceuticals Inc [2016-01-28] 8.9
Consonance Capital Management LP Enanta Pharmaceuticals Inc [2015-02-17] 0.1
Eagle Asset Management Inc Enanta Pharmaceuticals Inc [2015-01-07] 5.96
Dworsky Alan J Enanta Pharmaceuticals Inc [2014-09-18] 5.4
RA Capital Management LLC Enanta Pharmaceuticals Inc [2014-04-01] 8.0
TVM V Life Science Ventures GmbH & Co KG Enanta Pharmaceuticals Inc [2014-02-14] 14.1
FMR LLC Enanta Pharmaceuticals Inc [2014-02-14] 0.0
MRNA - Holdings LLC Enanta Pharmaceuticals Inc [2014-02-13] 0.1
AbbVie Inc Enanta Pharmaceuticals Inc [2014-02-07] 5.97
Shionogi & Co Ltd Enanta Pharmaceuticals Inc [2014-01-29] 8.9
HBM Healthcare Investments Cayman Ltd Enanta Pharmaceuticals Inc [2013-04-03] 8.69
Form 3/4/5 Filer 2011 - 2025
Enanta Pharmaceuticals Inc
Rottinghaus Scott T.
Vance Terry
Carter Bruce L A
Peterson Kristine
Hata Yujiro S
Foletta Mark G
Russell Lesley
Mellett Paul J
Luu Brendan
Kieffer Tara Lynn
Or Yat Sun
Luly Jay R.
Kowalsky Matthew Paul
Gardiner Nathaniel S.
Adda Nathalie
Golumbeski George
Buckley Stephen Jr.
Ocain Tim
Afting Ernst-Guenter
TVM IV Management GmbH & Co. KG
TVM Capital GmbH
Birner Hubert
TVM IV GmbH & Co KG
TVM Medical Ventures GmbH & Co KG
Fischer Stefan
TVM V Life Science Ventures Management GmbH & Co. KG
TVM V Life Science Ventures GmbH & Co KG
Goll Alexandra
Schuhsler Helmut
Goldberg Marc E.
OBP (Bermuda) III - Holdings LLC
OBP III - Holdings LLC
Saints Capital Granite, LLC
Saints Capital Granite LP
OBP (Adjunct) III - Holdings LLC
mRNA - Holdings LLC
Shionogi & Co Ltd
Verdine Gregory L.
Poorvin David
Form 13F Holdings
Firm Period DFND Voting Shares
Farallon Capital Management LLC [2025-06-30] OTR 2,122,262 2,122,262
Krensavage Asset Management LLC [2025-06-30] SOLE 2,114,444 2,114,444
Vanguard Group Inc [2025-06-30] SOLE 0 1,953,197
BlackRock, Inc. [2025-06-30] SOLE 1,808,125 1,846,905
Millennium Management LLC [2025-06-30] SOLE 1,458,593 1,508,593
Marshall Wace LLP [2025-06-30] OTR 0 857,412
Stonepine Capital Management LLC [2025-06-30] SOLE 604,066 604,066
Janus Henderson Group PLC [2025-06-30] DFND 0 523,743
Geode Capital Management LLC [2025-06-30] DFND 485,797 485,797
State Street Corp [2025-06-30] DFND 438,366 470,270
Renaissance Technologies LLC [2025-06-30] SOLE 469,500 469,500
AQR Capital Management LLC [2025-06-30] DFND 376,283 384,975
Morgan Stanley [2025-06-30] DFND 278,952 286,526
D. E. Shaw & Co., Inc. [2025-06-30] DFND 273,647 282,276
Trexquant Investment LP [2025-06-30] SOLE 264,958 264,958
Dimensional Fund Advisors LP [2025-06-30] SOLE 235,991 259,819
Northern Trust Corp [2025-06-30] DFND 193,672 193,770
Jacobs Levy Equity Management Inc [2025-06-30] SOLE 157,406 192,070
SIO Capital Management LLC [2025-06-30] SOLE 178,774 178,774
Charles Schwab Investment Management Inc [2025-06-30] SOLE 164,647 164,647
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 149,178 149,178
Two Sigma Advisers LP [2025-06-30] SOLE 124,800 133,600
JPMorgan Chase & Co [2025-06-30] DFND 106,840 130,433
Tang Capital Management LLC [2025-06-30] OTR 0 126,655
Goldman Sachs Group Inc [2025-06-30] DFND 115,235 116,135
Assenagon Asset Management S.A. [2025-06-30] SOLE 106,380 106,380
PDT Partners LLC [2025-06-30] SOLE 86,752 86,752
Qube Research & Technologies Ltd [2025-06-30] SOLE 83,912 83,912
Two Sigma Investments LP [2025-06-30] SOLE 78,455 78,455
SEI Investments Co [2025-06-30] SOLE 73,853 73,853
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com